Abstract
In this study, the role of highly structured water molecules present in the active site of the leukotriene A4 hydrolase (LTA4H) enzyme has been critically examined through the docking experiments. It was observed that different experiments were necessary to perform the docking studies. The ligands capable of displacing or interacting with bound-water(s) displayed different binding poses as well as the scores. The docking scores E (CvdW) from Glide and ChemScore (CS) from FlexX, with and without bound-waters, obtained through different docking experiments were used to construct two structure guided bi-parametric linear regression models using the IC50 enzyme activity data. The predictive squared correlation coefficients (Q2) obtained for these models, with and without bound waters, were found to be 0.73 and 0.67, respectively. These models were validated using test and validated sets of compounds. Utilizing these QSAR models, 409 proposed structures were docked and their respective predicted IC50 data were generated. From the in-silico evaluation of these 409 proposed structures representing diverse chemotypes, 39 compounds were triaged, synthesized and evaluated in the enzyme inhibition assay. The predicted and experimental biological data (IC50) was correlated and the square of the correlation coefficient (R2) between the observed and calculated IC50 was found to be 0.87.
Keywords: Crystallographic waters, structure based QSAR, docking, scoring function.
Current Computer-Aided Drug Design
Title:A Structure Guided QSAR: A Rapid and Accurate technique to predict IC50: A Case Study
Volume: 11 Issue: 2
Author(s): Rama K. Mishra and Jasbir Singh
Affiliation:
Keywords: Crystallographic waters, structure based QSAR, docking, scoring function.
Abstract: In this study, the role of highly structured water molecules present in the active site of the leukotriene A4 hydrolase (LTA4H) enzyme has been critically examined through the docking experiments. It was observed that different experiments were necessary to perform the docking studies. The ligands capable of displacing or interacting with bound-water(s) displayed different binding poses as well as the scores. The docking scores E (CvdW) from Glide and ChemScore (CS) from FlexX, with and without bound-waters, obtained through different docking experiments were used to construct two structure guided bi-parametric linear regression models using the IC50 enzyme activity data. The predictive squared correlation coefficients (Q2) obtained for these models, with and without bound waters, were found to be 0.73 and 0.67, respectively. These models were validated using test and validated sets of compounds. Utilizing these QSAR models, 409 proposed structures were docked and their respective predicted IC50 data were generated. From the in-silico evaluation of these 409 proposed structures representing diverse chemotypes, 39 compounds were triaged, synthesized and evaluated in the enzyme inhibition assay. The predicted and experimental biological data (IC50) was correlated and the square of the correlation coefficient (R2) between the observed and calculated IC50 was found to be 0.87.
Export Options
About this article
Cite this article as:
K. Mishra Rama and Singh Jasbir, A Structure Guided QSAR: A Rapid and Accurate technique to predict IC50: A Case Study, Current Computer-Aided Drug Design 2015; 11 (2) . https://dx.doi.org/10.2174/1573409911666150702100839
DOI https://dx.doi.org/10.2174/1573409911666150702100839 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability Utilizing Natural Agents
Current Drug Targets A Potential Role of Diet in Modulating Peroxisome Proliferator-Activated Receptor (PPAR)-Mediated Signalling in Arthritis
Current Rheumatology Reviews Mitogen-Induced Interferon Gamma Production in Human Whole Blood: The Effect of Heat and Cations
Current Pharmaceutical Biotechnology Design and Structure of Peptide and Peptidomimetic Antagonists of Protein- Protein Interaction
Current Protein & Peptide Science Possible Consequences of Blocking Transient Receptor Potential Vanilloid 1
Current Pharmaceutical Biotechnology Soybean Antigen Proteins and their Intestinal Sensitization Activities
Current Protein & Peptide Science Patent Selections
Recent Patents on Anti-Infective Drug Discovery Update on MDS Therapy: From Famine to Feast
Cardiovascular & Hematological Agents in Medicinal Chemistry Cytokine Production by SaOS-2 and Mononuclear Cells Cultivated on Alginate Titanium Surfaces Doped with Calcium Phosphates
Current Bionanotechnology (Discontinued) Targeted Inhibition of Angiogenic Factors in AIDS-related Disorders
Current Drug Targets - Infectious Disorders CCL2-CCR2 Signaling in Disease Pathogenesis
Endocrine, Metabolic & Immune Disorders - Drug Targets ATP Binding Cassette Transporter A1 (ABCA1) Associated Proteins:Potential Drug Targets in the Metabolic Syndrome and Atherosclerotic Disease?
Current Pharmaceutical Biotechnology Preparation and Characterization of Mixed Polymeric Micelles as a Versatile Strategy for Meloxicam Oral Administration
Letters in Drug Design & Discovery A Century of Thioxanthones: Through Synthesis and Biological Applications
Current Medicinal Chemistry Genomics Strategies for Antifungal Drug Discovery - From Gene Discovery to Compound Screening
Current Pharmaceutical Design Aging and Neuroinflammatory Disorders: New Biomarkers and Therapeutic Targets
Current Pharmaceutical Design Is Metformin a Therapeutic Paradigm for Colorectal Cancer: Insight into the Molecular Pathway?
Current Drug Targets Insights into the Structural Features, Conformational Stability and Functional Activity of the <i>Olneya tesota</i> PF2 Lectin
Protein & Peptide Letters Update on the Development of microRNA and siRNA Molecules as Regulators of Cell Physiology
Recent Patents on DNA & Gene Sequences Therapeutic Management of COVID-19 Patients: Clinical Manifestation and Limitations
Current Pharmaceutical Design